Form 4: ADC Therapeutics Director's Shareholding Adjusted for Tax Obligations

ADC Therapeutics SA Director Jean-Pierre Bizzari's beneficial ownership of common shares was adjusted due to the withholding of 12,600 shares for tax obligations related to vested restricted share units.

Summary

• Jean-Pierre Bizzari, a Director of ADC Therapeutics SA (ADCT), reported a change in his beneficial ownership of common shares.
• On June 13, 2025, 12,600 common shares were disposed of by the issuer.
• This disposition was a withholding by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of previously granted restricted share units.
• The shares were valued at $3.58 per share for the purpose of this transaction.
• Following this transaction, Jean-Pierre Bizzari directly beneficially owns 106,902 common shares.

Sentiment

Score: 5

Explanation: The transaction is a standard administrative event related to equity compensation and tax withholding, carrying a neutral sentiment regarding the company's operational or financial performance.

Positives

• The transaction indicates the vesting of restricted share units (RSUs) for Director Jean-Pierre Bizzari, which is a positive for the individual's compensation and retention.

Negatives

• The disposition of shares is not a sale by the director but a withholding by the issuer to cover tax liabilities, which is a standard administrative procedure and does not reflect a negative sentiment towards the company.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation and tax withholding, which is a common administrative event across all industries for publicly traded companies and does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal direct impact as it represents a routine tax withholding related to director compensation, not a discretionary sale by the director.
• Employees: Reflects standard equity compensation practices for executives, which can be a positive for talent retention.

Key Dates

Keywords

ADC Therapeutics, ADCT, Form 4, Insider Transaction, Share Ownership, Director, Restricted Share Units, Tax Withholding, Equity Compensation